Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Algernon Pharmaceuticals Inc
AGNPF
Primary Symbol:
C.AGN
Consumer Cyclical
Healthcare
Advertising Agencies
Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N...
-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:AGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(36)
•••
Justdosomedd
X
View Profile
View Bullboard History
Post by
Justdosomedd
on Aug 17, 2022 2:59pm
New Article on AGN From MedicalGold
As $AGN.C continues to progress with their research and development, a new article from MedicalGold highlights the numerous bullish fundamentals behind $AGN.C’s strategy. Their focus on
...more
(36)
•••
Justdosomedd
X
View Profile
View Bullboard History
Post by
Justdosomedd
on Aug 16, 2022 8:03pm
Promising Progress With Their Research
Utilizing already existing drugs for novel treatments gives several advantages, such as having a much lower risk of failure, safety, and more attractive pricing capabilities. Focusing on just the IPF
...more
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project
posted May 01, 2024 9:00am by
Viva Gold Corp.
-
|
Previously unknown areas of gold mineralization were discovered with longer lengths and higher gold grades than expected. 21.3 meters at 5.1 gpt Au was drilled as an approximate 40-meter offset to the west of TG2211 (57.9-meters at 5.0 gpt Au commencing at 40-meters depth). James Hesketh, President & CEO stated, “Many geologists go their whole careers without seeing drill results like these ...read more
(53)
•••
waves1
X
View Profile
View Bullboard History
Post by
waves1
on Aug 16, 2022 6:00pm
Full Phase 2a IPF study results coming soon
AGN is understandably consolidating after the big run last week - still watching closely ahead of the full Phase 2a study results for IPF and chronic cough coming in Q3 2022 as well as for any
...more
(53)
•••
waves1
X
View Profile
View Bullboard History
Post by
waves1
on Aug 15, 2022 6:49pm
AGN CEO on chronic kidney disease research program
AGN CEO on the chronic kidney disease research program with NP-251/Repirinast: https://www.youtube.com/watch?v=aMT0bnsIWPA&ab_channel=Proactive AGN is conducting a small phase 1 study
...more
(36)
•••
Justdosomedd
X
View Profile
View Bullboard History
Post by
Justdosomedd
on Aug 15, 2022 2:22pm
Natural Consolidation After Last Week's Run
$AGN.C is seeing some consolidation after last week’s big run as some investors take profits on their gains. Their model of using approved, safe, and well-established drugs for undiscovered uses has
...more
(75)
•••
StockHawk1
X
View Profile
View Bullboard History
Post by
StockHawk1
on Aug 12, 2022 5:45pm
AGN skyrocketing on CSE
$AGN.c closed 17.65% up today+ it is up 43% since Monday IMO this growth was likely sparked by the fact that its Ifenprodil drug was shown to reduce patients' 24-hour cough counts
...more
(53)
•••
waves1
X
View Profile
View Bullboard History
Post by
waves1
on Aug 12, 2022 4:38pm
AGN continuing its run w/ 40% increase in the past 5 days
AGN continues on its run - up another 18% for a total of over 40% in the past 5 days! As we finish off 2022 and head into 2023, AGN has a few potential catalysts coming up including the Phase 2a
...more
(36)
•••
Justdosomedd
X
View Profile
View Bullboard History
Post by
Justdosomedd
on Aug 11, 2022 4:33pm
Outperforming Over the Past Month
$AGN.C just broke through the $4.00 resistance level and is now up 10% so far today. This makes it one of the best-performing pharmaceutical companies over the past month, and looking at their phase 2
...more
(273)
•••
partystocker
X
View Profile
View Bullboard History
Post by
partystocker
on Aug 11, 2022 3:18pm
AGN.c SP sees big gains today.
Algernon Pharmaceuticals (CSE: AGN) is seeing some huge moves on the chart today following a big spike in volume on August 5. Today, shares hit $4.735, marking a 56% gain from recent lows.
...more
(1819)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Aug 10, 2022 5:22pm
Microdose Announces The 2nd Annual Microdose Awards
Miami, Florida--(Newsfile Corp. - August 9, 2022) - Microdose Psychedelic Insights, the leading guide to the business of psychedelics, is excited to announce the lineup of categories for the 2nd
...more
(36)
•••
Justdosomedd
X
View Profile
View Bullboard History
Post by
Justdosomedd
on Aug 10, 2022 3:27pm
Positive Performance With Recent Study Results
Algernon Pharmaceuticals is up another 11% today as the recently released results from the Ifenprodil IPF and Chronic Cough study continue to show signs of promise for both patients needing an
...more
(53)
•••
waves1
X
View Profile
View Bullboard History
Post by
waves1
on Aug 10, 2022 2:41pm
AGN up 11% w/ Proactive Virtual Forum Presentation
AGN up 11% today following the Proactive One2One Virtual Forum
...more
(6)
•••
DIYPortfolio
X
View Profile
View Bullboard History
Post by
DIYPortfolio
on Aug 09, 2022 5:15pm
👀👀🔥🔥 AGN.CA Algernon Pharmaceuticals
Check out Christopher Moreau discussing strokes & DMT: https://youtu.be/fSqhUwJ7kKk 80-85% of patients don't qualify for current stroke medication
(53)
•••
waves1
X
View Profile
View Bullboard History
Post by
waves1
on Aug 09, 2022 1:53pm
AGN up 17% - cheap psychedelic company heading to DMT trials
Big jump for AGN today up 17% to $3.75 today - still only a $7M market cap psychedelic company which could be the cheapest one heading into DMT trials... AGN is positively positioned as it
...more
(53)
•••
waves1
X
View Profile
View Bullboard History
Post by
waves1
on Aug 08, 2022 6:07pm
More positive data from AGN's phase 2 study!
"More positive data" from AGN's Phase 2 study
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results